Roche Holding AG (RHHVF) Stock Forecast & Price Target

Compare

411 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

RHHVF Analyst Ratings

Hold

5 Buy

3 Hold

4 Sell

Based on 12 analysts giving stock ratings to

Roche

Holding AG

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

RHHVF Stock 12 Month Forecast

Average Price Target

$347.51

▼(-3.51% Downside)

Based on 12 Wall Street analysts offering 12 month price targets for Roche Holding AG in the last 3 months. The average price target is $347.51 with a high forecast of $402.11 and a low forecast of $295.30. The average price target represents a -3.51% change from the last price of $360.14.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"269":"$269","336":"$336","403":"$403","302.5":"$302.5","369.5":"$369.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":402.10624,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$402.11</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":347.51,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$347.51</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":295.29677,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$295.30</span>\n  </div></div>","useHTML":true}}],"tickPositions":[269,302.5,336,369.5,403],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2025","6":"Apr<br/>2025","9":"Jul<br/>2025","12":"Oct<br/>2025","25":"Oct<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,353.22,356.98048,360.74096000000003,364.50144,368.26192000000003,372.0224,375.78288000000003,379.54336,383.30384000000004,387.06432,390.82480000000004,394.58528,398.34576000000004,{"y":402.10624,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,353.22,352.78076923076924,352.3415384615385,351.9023076923077,351.4630769230769,351.0238461538462,350.5846153846154,350.1453846153846,349.7061538461538,349.2669230769231,348.8276923076923,348.3884615384615,347.9492307692308,{"y":347.51,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,353.22,348.7643669230769,344.30873384615387,339.85310076923076,335.3974676923077,330.9418346153846,326.48620153846156,322.03056846153845,317.5749353846154,313.1193023076923,308.66366923076924,304.20803615384614,299.7524030769231,{"y":295.29677,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":302.36,"date":1727740800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 16</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":302.5,"date":1730419200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 17</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":276.29,"date":1733011200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 13</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":270.96,"date":1735689600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 15</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":302.9,"date":1738368000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 19</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":318.72,"date":1740787200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 18</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":329,"date":1743465600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 18</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":321.52,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 14</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":326.2,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 15</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":330.82,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 16</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":316.57,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 14</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":323.88,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 15</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":353.22,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$402.11

Average Price Target$347.51

Lowest Price Target$295.30

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Rajan Sharma

Goldman Sachs

$304.09→$311.63

Sell

-13.47%

Downside

Reiterated

10/06/25

Goldman Sachs Remains a Sell on Roche Holding AG (RHHVF)Goldman Sachs analyst Rajan Sharma raised the price target on Roche Holding (ROG:SW) (OTC: RHHBY) to CHF248.00 (from CHF242.00) while maintaining a Sell rating.

Veda Pharmyne

TR | OpenAI - 4o

$363.15→$397.08

Buy

10.26%

Upside

Reiterated

10/02/25

AI Generated ArticleAI Generated Article

Rajesh Kumar

HSBC

$358.13→$402.11

Buy

11.65%

Upside

Upgraded

10/01/25

HSBC upgrades Roche Holding AG (RHHVF) to a BuyWe upgrade Roche to a Buy (from Hold) as we raise our target price from CHF285.00 to CHF320.00 following updated medium‐term estimates centered on an expanding obesity portfolio and positive catalyst outlook.

Richard Vosser

J.P. Morgan

$318.54

Sell

-11.55%

Downside

Reiterated

09/29/25

Analysts Offer Insights on Healthcare Companies: Roche Holding AG (Other OTC: RHHVF) and Soleno Therapeutics (NASDAQ: SLNO)

David Evans

Kepler Capital

$395.82

Buy

9.91%

Upside

Reiterated

09/26/25

Roche Holding AG (RHHVF) Receives a Buy from Kepler Capital Kepler Cheuvreux analyst David Evans reiterated a Buy rating and CHF315.00 price target on Roche Holding (ROG:SW) (OTC: RHHBY).

Emmanuel Papadakis

Deutsche Bank

$295.3

Sell

-18.01%

Downside

Reiterated

09/24/25

Roche Holding AG (RHHVF) Receives a Sell from Deutsche Bank

Emily Field

Barclays

$345.56

Hold

-4.05%

Downside

Reiterated

09/24/25

Barclays Sticks to Their Hold Rating for Roche Holding AG (RHHVF)

Matthew Weston

UBS

$394.57

Buy

9.56%

Upside

Reiterated

09/23/25

UBS Keeps Their Buy Rating on Roche Holding AG (RHHVF)

Luisa Hector

Berenberg Bank

$364.41

Hold

1.19%

Upside

Reiterated

09/17/25

Berenberg Bank Keeps Their Hold Rating on Roche Holding AG (RHHVF)

Justin Smith

Bernstein

―

Buy

―

Reiterated

09/04/25

We rate the shares Outperform as we expect upto mid‐teens EPS upgrade potential. Moreover, despite encouraging progress under the new management team, in our view the pharma pipeline is unappreciated.

Sarita Kapila

Morgan Stanley

$359.38→$307.86

Sell

-14.52%

Downside

Downgraded

08/08/25

Roche Holding AG Faces Growth Challenges Amidst Competition and Regulatory Risks, Downgraded to Underweight

Elmar Kraus

DZ BANK AG

―

Buy

―

Reiterated

07/25/25

DZ BANK AG Reaffirms Their Buy Rating on Roche Holding AG (RHHVF)

Benjamin Jackson CFA

Jefferies

$339.28

Hold

-5.79%

Downside

Reiterated

07/24/25

Analysts Conflicted on These Healthcare Names: Roche Holding AG (Other OTC: RHHVF) and Thermo Fisher (NYSE: TMO)

Peter Verdult

Exane BNP Paribas

$376.97

Buy

4.67%

Upside

Initiated

04/16/25

BNP Paribas Exane Starts Roche Holding (ROG:SW) (RHHBY) at OutperformBNP Paribas Exane analyst Peter Verdult initiates coverage on Roche Holding (ROG:SW) (OTC: RHHBY) with a Outperform rating and a price target of CHF300.00.

Hans Engel

Erste Group

―

Hold

―

Downgraded

11/05/24

Erste Group Downgrades Roche Holding (ROG:SW) (RHHBY) to HoldErste Group analyst Hans Engel downgraded Roche Holding (ROG:SW) (OTC: RHHBY) from Buy to Hold.

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Rajan Sharma

Goldman Sachs

$304.09→$311.63

Sell

-13.47%

Downside

Reiterated

10/06/25

Veda Pharmyne

TR | OpenAI - 4o

$363.15→$397.08

Buy

10.26%

Upside

Reiterated

10/02/25

AI Generated ArticleAI Generated Article

Rajesh Kumar

HSBC

$358.13→$402.11

Buy

11.65%

Upside

Upgraded

10/01/25

Richard Vosser

J.P. Morgan

$318.54

Sell

-11.55%

Downside

Reiterated

09/29/25

Analysts Offer Insights on Healthcare Companies: Roche Holding AG (Other OTC: RHHVF) and Soleno Therapeutics (NASDAQ: SLNO)

David Evans

Kepler Capital

$395.82

Buy

9.91%

Upside

Reiterated

09/26/25

Roche Holding AG (RHHVF) Receives a Buy from Kepler Capital Kepler Cheuvreux analyst David Evans reiterated a Buy rating and CHF315.00 price target on Roche Holding (ROG:SW) (OTC: RHHBY).

Emmanuel Papadakis

Deutsche Bank

$295.3

Sell

-18.01%

Downside

Reiterated

09/24/25

Roche Holding AG (RHHVF) Receives a Sell from Deutsche Bank

Emily Field

Barclays

$345.56

Hold

-4.05%

Downside

Reiterated

09/24/25

Barclays Sticks to Their Hold Rating for Roche Holding AG (RHHVF)

Matthew Weston

UBS

$394.57

Buy

9.56%

Upside

Reiterated

09/23/25

UBS Keeps Their Buy Rating on Roche Holding AG (RHHVF)

Luisa Hector

Berenberg Bank

$364.41

Hold

1.19%

Upside

Reiterated

09/17/25

Berenberg Bank Keeps Their Hold Rating on Roche Holding AG (RHHVF)

Justin Smith

Bernstein

―

Buy

―

Reiterated

09/04/25

Sarita Kapila

Morgan Stanley

$359.38→$307.86

Sell

-14.52%

Downside

Downgraded

08/08/25

Roche Holding AG Faces Growth Challenges Amidst Competition and Regulatory Risks, Downgraded to Underweight

Elmar Kraus

DZ BANK AG

―

Buy

―

Reiterated

07/25/25

DZ BANK AG Reaffirms Their Buy Rating on Roche Holding AG (RHHVF)

Benjamin Jackson CFA

Jefferies

$339.28

Hold

-5.79%

Downside

Reiterated

07/24/25

Analysts Conflicted on These Healthcare Names: Roche Holding AG (Other OTC: RHHVF) and Thermo Fisher (NYSE: TMO)

Peter Verdult

Exane BNP Paribas

$376.97

Buy

4.67%

Upside

Initiated

04/16/25

Hans Engel

Erste Group

―

Hold

―

Downgraded

11/05/24

Erste Group Downgrades Roche Holding (ROG:SW) (RHHBY) to HoldErste Group analyst Hans Engel downgraded Roche Holding (ROG:SW) (OTC: RHHBY) from Buy to Hold.

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Roche Holding AG

1 Month

xxx

Success Rate

33/58 ratings generated profit

Average Return

+0.99%

reiterated a xxx

rating 13 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 56.90% of your transactions generating a profit, with an average return of +0.99% per trade.

3 Months

xxx

Success Rate

34/51 ratings generated profit

Average Return

+1.04%

reiterated a xxx

rating 8 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +1.04% per trade.

1 Year

Richard VosserJ.P. Morgan

Success Rate

26/51 ratings generated profit

Average Return

-0.33%

reiterated a sell rating 8 days ago

Copying Richard Vosser's trades and holding each position for 1 Year would result in 50.98% of your transactions generating a profit, with an average return of -0.33% per trade.

2 Years

xxx

Success Rate

31/58 ratings generated profit

Average Return

+2.66%

reiterated a xxx

rating 13 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 53.45% of your transactions generating a profit, with an average return of +2.66% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

RHHVF Analyst Recommendation Trends

Rating

Jun 25

Jul 25

Aug 25

Sep 25

Oct 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, RHHVF has received 12 Buy Ratings, 4 Hold Ratings, and 6 Sell Ratings. RHHVF average Analyst price target in the past 3 months is 347.51.

Each month's total comprises the sum of three months' worth of ratings.

RHHVF Financial Forecast

RHHVF Earnings Forecast

Next quarter’s earnings estimate for RHHVF is $10.77 with a range of $10.67 to $10.86. The previous quarter’s EPS was $13.91. RHHVF beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year RHHVF has Outperformed its overall industry.

RHHVF Sales Forecast

Next quarter’s sales forecast for RHHVF is $39.49B with a range of $38.92B to $40.11B. The previous quarter’s sales results were $38.85B. RHHVF beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year RHHVF has Outperformed its overall industry.

RHHVF Stock Forecast FAQ

What is RHHVF’s average 12-month price target, according to analysts?

Based on analyst ratings, Roche Holding AG’s 12-month average price target is 347.51.

What is RHHVF’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for RHHVF, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is RHHVF a Buy, Sell or Hold?

Roche Holding AG has a consensus rating of Hold which is based on 5 buy ratings, 3 hold ratings and 4 sell ratings.

What is Roche Holding AG’s price target?

The average price target for Roche Holding AG is 347.51. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $402.11 ,the lowest forecast is $295.30. The average price target represents -3.51% Decrease from the current price of $360.14.

What do analysts say about Roche Holding AG?

Roche Holding AG’s analyst rating consensus is a Hold. This is based on the ratings of 12 Wall Streets Analysts.

How can I buy shares of RHHVF?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Roche Holding AG (RHHVF) Stock Forecast & Price Target

RHHVF Analyst Ratings

RHHVF Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Roche Holding AG

RHHVF Analyst Recommendation Trends

RHHVF Financial Forecast

RHHVF Earnings Forecast

RHHVF Sales Forecast

RHHVF Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts